Skip to main content Skip to search Skip to main navigation
Please feel free to contact us via our order hotline:
07626 974 9700
(Mon-Fri 8am-8pm, Sat 8am-12pm)

Wilson’s disease – successfully treated with Cuprum metallicum

News

(Key symptom: spasmodic control that erupts into violent attacks)
   

11_0629_similia_cuprum.jpg

Wilson's disease is a very rare autosomal-recessive hereditary disorder characterised by copper accumulation and subsequent copper poisoning. It is still little researched in the medical world and often remains undiagnosed due to lack of knowledge. It is named after the American neurologist Alexander Kinnear Wilson, who was particularly struck at the beginning of the 19th century by the fact that both the brain and the liver of the same patient showed life-threatening damage.

In a patient with Wilson's disease, a mutation of the ATP7B gene causes impaired copper excretion from the liver (blood picture: the ceruloplasmin level is usually very low). The liver can store additional copper, but at some point the storage capacity is exhausted and the liver is gradually damaged by the excess copper. The tissue suffers so-called oxidative damage. In most Wilson patients the liver damage begins in the third or fourth year of life and presents with elevated liver values. Liver diseases typically present in adolescence or early adulthood as hepatitis with fatigue, jaundice and/or ascites, as liver cirrhosis or even as liver failure. The excess copper is then released into the blood and begins to accumulate in other organs. After the liver, the brain is the most sensitive organ. Movement disorders resulting from brain damage do not manifest as muscle weakness but as difficulties in controlling muscle actions and movements. Speech problems or slurred speech are often the first noticed changes.

Another nervous system symptom is tremor (a shaking or trembling often of the hands, but also of the upper and lower limbs and the head). Another conspicuous feature is dystonia, a type of cramping or stiffening of the muscles. Because of tremor and/or dystonia, Wilson patients are often mistakenly diagnosed as Parkinson's patients. The final important nervous system symptom is deteriorating coordination, for example when trying to write legibly, eat or button clothing. The patient trips and falls unusually often.

Many Wilson patients also show behavioural abnormalities resulting from brain damage. These include poor control of emotions, which can lead to outbursts of anger, bouts of crying, depression and sometimes bizarre behaviour. Patients often have difficulty concentrating on tasks; in children school grades can deteriorate. Short-term memory loss and insomnia are also common problems.

After diagnosis, Wilson's disease is treated with decoppering medications such as penicillamine or trientine. The side-effect-free zinc acetate (trade name: Wilzin) is in Germany not used as initial therapy but only as maintenance therapy. Penicillamine was the first available medication but is very toxic and associated with many side effects (the skin of a 30-year-old patient, for example, then looked like that of a 60-year-old). In the initial treatment of neurological Wilson's disease it led to a permanent worsening of neurological symptoms in 25% of patients. The newer drug trientine is less toxic, but it can, among other things, cause kidney damage, anaemia and autoimmune diseases (such as systemic lupus erythematosus).

Now to my story. In March 2009 Wilson's disease was diagnosed in my 11-year-old daughter by chance after a syncope and frequent dizziness with weakness. She had a fatty liver and markedly elevated liver values as well as high cholesterol. Since this is a copper storage disease, I acted according to Hahnemann's motto: "Similia similibus curentur" and from the end of March began to treat my daughter with Cuprum metallicum C200. Some of her main symptoms included mind – fear – of failure, need for constant reassurance, mind – colour – bluish – around the mouth, stomach – pain – cramping, extremities – cramps – feet.

After extensive research I unfortunately found that until then no one had successfully treated this life-threatening disease with homeopathy. Because of the severe side effects we decided against the two drugs penicillamine and trientine. We wanted to continue to treat our daughter with Cuprum metallicum and the side-effect-free zinc acetate (Wilzin). After only 4 months of treatment with Cuprum metallicum, my daughter no longer had a fatty liver and was doing brilliantly; her cholesterol levels were normal and her liver values were slowly recovering. Despite the positive development with Cuprum metallicum, the additional decoppering therapy with zinc acetate was declared insufficient and vehemently rejected by all German professors, even though extensive studies by Prof. Brewer from the USA and Italy and Prof. Ferenci of the AKH Vienna confirm the effectiveness of zinc acetate. With massive threats (the youth welfare office was even mentioned!) three professors from the university hospitals of Regensburg, the Hauner Children's Clinic in Munich and Starnberg tried to force us to take these medications and were not willing to study, let alone use, the new side-effect-free therapy with zinc acetate. Thus, in January 2010 we began the additional decoppering therapy (Wilzin 3 x 25 mg/day) in Austria with Prof. Ferenci from the AKH Vienna and our paediatrician. It was incredible: after only 1 month of treatment with Wilzin all liver values were normal. The liver values from 29.12.2008 were GPT: 243, GOT: 115 and γ-GT: 27; on 22.1.2010 they were only GPT: 54, GOT: 42 and γ-GT: 17. Normally zinc takes 6 to 12 months to reduce copper toxicity and years to return liver values to normal. Neither Prof. Brewer nor Prof. Ferenci had ever seen such an astonishing and rapid course under pure zinc therapy. It is now suspected that thanks to the 9-month treatment with Cuprum metallicum the body was already largely decoppered and zinc cleared up the rest.

Further evidence for this suspicion is the penicillamine test performed on my daughter in October 2009 at the Regensburg University Hospital. When administering a daily dose of 4 x 250 mg penicillamine, the 24-hour collected urine should show a copper increase of > factor 10 or in children > 1600 µg/day. This test is also used for the diagnosis of Wilson's disease. In my daughter's case the copper excretion rose only by a factor of 5, i.e. from 150 µg/day to 753 µg/day. Had we not diagnosed Wilson's disease genetically beforehand, this result would actually have been proof that she could not have Wilson's disease. During the one-day treatment with penicillamine my daughter collapsed twice without reason and showed an opisthotonus. This known side effect of exacerbating neurological symptoms strengthened our decision not to use penicillamine.

One month after starting zinc treatment we immediately reduced the daily dose from 3 x 25 mg to 2 x 25 mg Wilzin because the first tablet caused severe nausea on an empty stomach. Although the zinc dose was reduced after 1 year to about 1 tablet/day, the liver values remained stable. This low zinc dose alone cannot be sufficient and suggests that Cuprum metallicum addressed the genetic defect.

Course of treatment of Wilson's disease with Cuprum metallicum

End of March 2009: Cuprum met. C200 3 times daily for 3 days

  • after 1 week massive rash on the face (cheeks) and on the backs of the hands (red, scaly, itchy, bleeding)
  • 1 episode of diarrhoea
  • Black, very hard dental deposits (plaques) in the upper jaw, which previously always had to be removed mechanically by the dentist, are slowly disappearing. According to the dentist's assumption these are a copper alloy.

10.4.2009: Repeat Cuprum met. C200 3 times daily for 3 days

  • mild rash on the backs of the hands

After 1.5 weeks Cuprum LM6 weekly

  • Fading of the spider naevi on the cheeks (more on the left than the right)
  • Brownish spots on the right forehead are slowly disappearing
  • Very balanced, cheerful
  • Further improvement in concentration and school performance
  • No more tiredness (previously often lay down on the floor after school)

Cuprum met. LM12 every 4–5 days (from July 2009)

  • Stool much more frequent (previously once every 1–2 days, now 3 times daily)
  • Recurring stabbing pains in the liver and spleen area
  • 29.7.2009 Diagnosis Klinikum Regensburg: suddenly no more fatty liver
  • 13.8.2009 again increased stabbing pains in the liver and spleen area. In the afternoon sudden weakness, temperature 39.5 °C, at night febrile delirium. Administration of Cuprum C200 3 x 1 tsp: fell asleep immediately and became calmer. At 3 a.m. the fever was suddenly gone. Woke in the morning and was fit. The spider naevi on the left were hardly visible.
  • 24.8.2009 strong, musty, sweet body odour for 3 days
  • 3.9.2009 blue lips after Cuprum LM12 and the same rash (as at the start of therapy with Cuprum C200) reappears on the backs of the hands for 1 week (red, scaly, itchy, bleeding)
  • 14.9.2009 bending of the head backwards (like an opisthotonus). Occurred more frequently previously during states of exhaustion.
  • 29.9.2009 sore throat + headache + left earache. 3 x Cuprum met. C200. On 30.9.2009 no more sore throat, stabbing pains under the liver on the right.
  • 8.10.2009 violent tantrum, overextended the head backwards, banged the head on the tiled floor (said: "everything is a cramp!"). On 11.10.2009 switch to Cuprum LM18. Reaction: nosebleed on the left the next day. Mood more balanced and very clingy.
  • Scalp rash crusty, bleeding from February 2010 + rough, partly cracked, bloody backs of hands recurring. Started Cuprum LM19 on 24.6.2010.
  • After starting Wilzin: 1.5 kg weight gain within 1 month + start of breast development. The black deposits on the teeth return slightly (due to the zinc).
  • Cuprum LM19 was effective until August 2010. Old symptoms of dizziness, slight nausea, stabbing pains in the liver area reappeared.
  • 17.10.2010 dizziness, nausea and almost fainting. Acute treatment with
    Cuprum met. C200. All symptoms disappeared within minutes. Cuprum met. LM19 had been exhausted.
  • Switch to Cuprum met. LM20 (21.9.2010–1.2.2011) every 14 days. Since the start of therapy no syncope, no nausea with weakness. Very good school performance. All black deposits on the teeth have disappeared again, as she now only takes about 1 tablet Wilzin/day.

Treatment with Wilzin

Start: 14.1.2010, daily 3 x 25 mg

Usual course of treatment with Wilzin

Cuprum metallicum + Wilzin

Copper in urine:  at the start of therapy very high copper excretion

Copper in urine before Wilzin (112), no increase after Wilzin, but a decrease

Normally a decline in copper excretion to 125 µg/24 h is seen after 6 to 12 months.

after 1 M: 91.6 (reduction to 2 x 25 mg)
after 2 M: 75.9
after 4 M: 76.5 (reduction to 1.5 tablets/day)
after 6 M: 62.7
after 12 M: 82.1 (reduction to 1 tablet/day)

Usually many years of therapy pass before the concentration of copper in the urine falls into the normal
range of 20–50 µg/24 h urine!

 

 

Zinc in urine:
after 1 M: 1805
after 2 M: 1590
after 4 M: 760
after 6 M: 569
after 12 M: 730

Blood values

Normally zinc requires 6 to 12 months to reduce copper toxicity.

Liver values:
after 1 M: GOT: 42, GPT: 54, γ-GT:17, AP: 490, GLDH: 3.5
after 2 M: GOT: 38, GPT: 48, γ-GT: 16, AP: 458, GLDH: 3.5
after 4 M: GOT: 48, GPT: 83, γ-GT: 20, AP:408, GLDH: 7.8
after 6 M: GOT: 41, GPT: 57, γ-GT: 18, AP: 430, GLDH: 4.1
after 12 M.: GOT: 46, GPT: 84, γ-GT: 21, AP: 432, GLDH: 7.4

 

after 1 M: Zinc: 319, Cu: 28, Ceruloplasmin: 0.07
after 2 M: Zinc: 168, Cu: 25, Ceruloplasmin: 0.07
after 4 M: Zinc: 160, Cu: 26, Ceruloplasmin: 0.06
after 6 M: Zinc: 205, Cu: 22, Ceruloplasmin: 0.05
after 12 M: Zinc: 176, Cu: 25, Ceruloplasmin: 0.05

In my clinical experience, Cuprum metallicum is not only the remedy for hepatic copper storage disorder, but should also be considered in disabled patients, patients with Parkinson-like symptoms, in autism, spasms, cramps of all kinds and ADHD.
At this point I would like to once again warmly thank my teacher Mohinder Singh Jus for his tireless teaching of healing valves, when the "simillimum" was found. Without his knowledge I would never have had the strength and confidence to endure this 'psychothriller' for so long.

**************************************************************************
>> Further information about Cuprum metallicum can be found in the current Similia issue (7.2011)

**************************************************************************

Sources
AWMF online 2008. Guidelines of the German Society of Neurology – Wilson's Disease. Available at: www.awmf.org/uploads/tx_szleitlinien/030-091.pdf (downloaded 4.1.2010).

Brewer, George J. 2006. Wilson's Disease – A Guide for Patients and Their Relatives on Wilson's Disease and Copper Issues. Berlin. (Available free from Ophan Europe (Germany) GmbH, D-63128 Dietzenbach, Tel. 0049-(0)6074/812160)

**************************************************************************
HP Gabriele Spooren-Bunzel
SHZ-certified as therapist and lecturer
1.3.2011
**************************************************************************

Gabriele Spooren-Bunzel